MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 41 filers reported holding MEI PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $98,000 | +7.7% | 41,154 | -27.0% | 0.00% | 0.0% |
| Q1 2017 | $91,000 | +89.6% | 56,340 | +68.7% | 0.00% | +200.0% |
| Q4 2016 | $48,000 | -11.1% | 33,403 | +8.9% | 0.00% | 0.0% |
| Q3 2016 | $54,000 | +145.5% | 30,681 | +77.6% | 0.00% | 0.0% |
| Q1 2016 | $22,000 | 0.0% | 17,277 | +24.0% | 0.00% | – |
| Q4 2015 | $22,000 | -15.4% | 13,934 | -8.3% | 0.00% | – |
| Q2 2015 | $26,000 | -69.8% | 15,192 | +12.2% | 0.00% | -100.0% |
| Q2 2014 | $86,000 | – | 13,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |